Functional Specialization of Dendritic Cell Subsets

Encyclopedia of Cell Biology

Volumn 3, Issue , 2016, Pages 588-604

  Heidkamp, G F ^a   Lehmann, C H K ^a   Heger, L ^a   Baransk, A ^a   Hoffmann, A ^a   Luhr J ^a   Dudziak, D ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Antigen presentation; Antigen processing; Antigen targeting; Autophagy; CLR; Cross presentation; DC; Dendritic cell subsets; FcR; Immune responses; MHC I; MHC II; PDC; TLR

Indexed keywords

EID: 85016893633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-394447-4.30076-1     Document Type: Chapter

References (308)

1. Ackerman A.L., Giodini A., Cresswell P. A role for the endoplasmic reticulum protein retrotranslocation machinery during crosspresentation by dendritic cells. Immunity 2006, 25:607-617.
2. Agarraberes F.A., Terlecky S.R., Dice J.F. An intralysosomal hsp70 is required for a selective pathway of lysosomal protein degradation. Journal of Cell Biology 1997, 137(4):825-834.
3. Akir S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124(4):783-801. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16497588.
4. Amsen D., Blander J.M., Lee G.R., et al. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 2004, 117(4):515-526.
5. Arrigo A.P., Tanaka K., Goldberg A.L., et al. Identity of the 19S "prosome" particle with the large multifunctional protease complex of mammalian cells (the proteasome). Nature 1988, 331:192-194.
6. Arunachalam B., Phan U.T., Geuze H.J., Cresswell P. Enzymatic reduction of disulfide bonds in lysosomes: Characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proceedings of the National Academy of Sciences of the United States of America 2000, 97(2):745-750.
7. Asselin-Paturel C., Brizard G., Chemin K., et al. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. Journal of Experimental Medicine 2005, 201(7):1157-1167.
8. Bachem A., Güttler S., Hartung E., et al. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. Journal of Experimental Medicine 2010, 207(6):1273-1281.
9. Bailey-Bucktrout S.L., Caulkins S.C., Goings G., et al. Cutting edge: Central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. Journal of Immunology 2008, 180(10):6457-6461.
10. Bakke O., Dobberstein B. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990, 63:707-716.
11. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annual Review of Immunology 2000, 18:767-811.
12. Banchereau J., Cohn F., Inaba K., et al. Remembering Ralph Steinman. Journal of Experimental Medicine 2011, 208:2343-2347.
13. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
14. Bandoh N., Ogino T., Cho H.S., et al. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies. Tissue Antigens 2005, 66(3):185-194.
15. Barral D.C., Brenner M.B. CD1 antigen presentation: How it works. Nature Reviews. Immunology 2007, 7(12):929-941.
16. Basha G., Omilusik K., Chavez-Steenbock A., et al. A CD74-dependent MHC class I endolysosomal cross-presentation pathway. Nature Immunology 2012, 13(3):237-245.
17. Bedoui S., Whitney P.G., Waithman J., et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nature Immunology 2009, 10(5):488-495.
18. Bendall S.C., Nolan G.P., Roederer M., Chattopadhyay P.K. A deep profiler's guide to cytometry. Trends in Immunology 2012, 33(7):323-332.
19. Bevan M.J. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. Journal of Immunology 1976, 117(6):2233-2238.
20. Bjorkman P., Saper M.A., Samraoui B., et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
21. Bogunovic M., Ginhoux F., Helft J., et al. Origin of the lamina propria dendritic cell network. Immunity 2009, 31(3):513-525.
22. Boltjes A., van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Frontiers in Immunology 2014, 5:131.
23. Bonifaz L.C., Bonnyay D., Mahnke K., et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Journal of Experimental Medicine 2002, 196(12):1627-1638.
24. Bonifaz L.C., Bonnyay D.P., Charalambous A., et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. Journal of Experimental Medicine 2004, 199(6):815-824.
25. Boscardin S.B., Hafalla J.C., Masilamani R.F., et al. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. Journal of Experimental Medicine 2006, 203(3):599-606.
26. Brewig N., Kissenpfennig A., Malissen B., et al. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. Journal of Immunology (Baltimore, MD: 1950) 2009, 182(2):774-783.
27. Brossart P., Bevan M.J. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines. Blood 1997, 90:1594-1599.
28. Burgdorf S., Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Current Opinion in Immunology 2008, 20(1):89-95.
29. Burrows S.R., Rossjohn J., McCluskey J. Have we cut ourselves too short in mapping CTL epitopes?. Trends in Immunology 2006, 27(1):11-16.
30. Cao W., Lee S.H., Lu J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochemical Journal 2005, 385(Pt 1):85-93.
31. Cascio P., Hilton C., Kisselev A.F., Rock K.L., Goldberg A.L. 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO Journal 2001, 20(10):2357-2366.
32. Caton M.L., Smith-Raska M.R., Reizis B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. Journal of Experimental Medicine 2007, 204(7):1653-1664.
33. Cebrian I., Visentin G., Blanchard N., et al. Sec22b regulates phagosomal maturation and antigen crosspresentation by dendritic cells. Cell 2011, 147(6):1355-1368.
34. Cella M., Engering A., Pinet V., Pieters J., Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388(6644):782-787.
35. Cella M., Jarrossay D., Facchetti F., et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nature Medicine 1999, 5(8):919-923.
36. Cervantes-Barragan L., Lewis K.L., Firner S., et al. Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proceedings of the National Academy of Sciences 2012, 109(8):3012-3017.
37. Chang S.-C., Momburg F., Bhutani N., Goldberg A.L., et al. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. Proceedings of the National Academy of Sciences of the United States of America 2005, 102(47):17107-17112.
38. Chapman H.A. Endosomal proteases in antigen presentation. Current Opinion in Immunology 2006, 18(1):78-84.
39. Chattopadhyay P.K., Hogerkorp C.M., Roederer M. A chromatic explosion: The development and future of multiparameter flow cytometry. Immunology 2008, 125:441-449.
40. Chattopadhyay P.K., Roederer M. Cytometry: Today's technology and tomorrow's horizons. Methods 2012, 57:251-258.
41. Chopin M., Allan R.S., Belz G.T. Transcriptional regulation of dendritic cell diversity. Frontiers in Immunology 2012, 3:1-12.
42. Chow A., Toomre D., Garrett W., Mellman I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 2002, 418:988-994.
43. Ciechanover A. Proteolysis: From the lysosome to ubiquitin and the proteasome. Nature Reviews. Molecular Cell Biology 2005, 6:79-87.
44. Cohn L., Chatterjee B., Esselborn F., et al. Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3+ dendritic cells at cross presentation. Journal of Experimental Medicine 2013, 210(5):1049-1063.
45. Colbert J.D., Matthews S.P., Miller G., Watts C. Diverse regulatory roles for lysosomal proteases in the immune response. European Journal of Immunology 2009, 39:2955-2965.
46. Cole D.K., Edwards E.S., Wynn K.K., et al. Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. Journal of Immunology (Baltimore, MD: 1950) 2010, 185:2600-2610.
47. Conus S., Perozzo R., Reinheckel T., et al. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. Journal of Experimental Medicine 2008, 205(3):685-698.
48. Conus S., Simon H.U. Cathepsins and their involvement in immune responses. Swiss Medical Weekly 2010, 140:1-8.
49. Cros J., Cagnard N., Woollard K., et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010, 33(3):375-386.
50. Crotzer V.L., Blum J.S. Autophagy and adaptive immunity. Immunology 2010, 131(1):9-17.
51. Crozat K., Guiton R., Contreras V., et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. Journal of Experimental Medicine 2010, 207(6):1283-1292.
52. Cuervo A.M., Dice J.F. A receptor for the selective uptake and degradation of proteins by lysosomes. Science (New York, NY) 1996, 273(5274):501-503.
53. de Heer H.J., Hammad H., Soullié T., et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. Journal of Experimental Medicine 2004, 200(1):89-98.
54. Delamarre L., Pack M., Chang H., Mellman I., Trombetta E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science (New York, NY) 2005, 307(5715):1630-1634.
55. Denzin L.K. Inhibition of HLA-DM mediated MHC class II peptide loading by HLA-DO promotes self tolerance. Frontiers in Immunology 2013, 4:1-5.
56. Diefenbach A., Jensen E.R., Jamieson A.M., Raulet D.H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 2001, 413(1991):165-171.
57. Dieu M.C., Vanbervliet B., Vicari A., et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. Journal of Experimental Medicine 1998, 188(2):373-386.
58. Do Y., Koh H., Park C.G., et al. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. European Journal of Immunology 2010, 40(10):2791-2796.
59. Döbel T., Kunze A., Babatz J., et al. FcγRIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens. Blood 2013, 121(18):3609-3618.
60. Doulatov S., Notta F., Eppert K., et al. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nature Immunology 2010, 11(7):585-593.
61. Duan F., Srivastava P.K. An invariant road to cross-presentation. Nature Immunology 2012, 13(3):207-208.
62. Dudziak D., Kamphorst A.O., Heidkamp G.F., et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007, 315(5808):107-111.
63. Dzionek A., Fuchs A., Schmidt P., et al. BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. Journal of Immunology (Baltimore, MD: 1950) 2000, 165(11):6037-6046.
64. Edelson B.T., Bradstreet T.R., Wumesh K.C., et al. Batf3-dependent CD11b low/- peripheral dendritic cells are GM-CSF-independent and are not required for th cell priming after subcutaneous immunization. PLoS One 2011, 6(10):1-10.
65. Edelson B.T., Wumesh K.C., Juang R., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. Journal of Experimental Medicine 2010, 207(4):823-836.
66. Edwards A.D., Chaussabel D., Tomlinson S., et al. Relationships among murine CD11c high dendritic cell subsets as revealed by baseline gene expression patterns. Journal of Immunology 2003, 171:47-60.
67. Eissing N., Heger L., Baranska A., et al. Easy performance of 6-color confocal immunofluorescence with 4-laser line microscopes. Immunology Letters 2014, 161(1):1-5.
68. Ekeruche-Makinde J., Miles J.J., van den Berg H.A., et al. Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood 2013, 121(7):1112-1123.
69. El-Sukkari D., Wilson N.S., Hakansson K., et al. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. Journal of Immunology (Baltimore, MD: 1950) 2003, 171(10):5003-5011.
70. Elinav E., Strowig T., Henao-Mejia J., Flavell R.A. Regulation of the antimicrobial response by NLR proteins. Immunity 2011, 34(5):665-679.
71. Evnouchidou I., Weimershaus M., Saveanu L., van Endert P. ERAP1-ERAP2 dimerization increases peptide-trimming efficiency. Journal of Immunology (Baltimore, MD: 1950) 2014, 193(2):901-908.
72. Fader C.M., Colombo M.I. Autophagy and multivesicular bodies: Two closely related partners. Cell Death and Differentiation 2009, 16:70-78.
73. Fallas J.L., Tobin H.M., Lou O., et al. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. Journal of Immunology (Baltimore, MD: 1950) 2004, 173(3):1549-1560.
74. Figdor C.G., van Kooyk Y., Adema G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nature Reviews. Immunology 2002, 2(2):77-84.
75. Filomeni G., De Zio D., Cecconi F. Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death and Differentiation 2014, 22(3):377-388.
76. Fogg D.K., Sibon C., Miled C., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311(5757):83-87.
77. Förster R., Schubel A., Breitfeld D., et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999, 99(1):23-33.
78. Früh K., Gossen M., Wang K., et al. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: A newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO Journal 1994, 13(14):3236-3244.
79. Gaczynska M., Rock K.L., Spies T., Goldberg A.L. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(20):9213-9217.
80. Geissmann F., Manz M.G., Jung S., et al. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327(5966):656-661.
81. Gerner M.Y., Kastenmuller W., Ifrim I., Kabat J., Germain R.N. Histo-cytometry: A method for highly multiplex quantitative tissue imaging analysis applied to dendritic cell subset microanatomy in lymph nodes. Immunity 2012, 37(2):364-376.
82. GeurtsvanKessel C.H., Willart M.A., van Rijt L.S., et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. Journal of Experimental Medicine 2008, 205(7):1621-1634.
83. Gil-Torregrosa B.C., Lennon-Duménil A.M., Kessler B., et al. Control of cross-presentation during dendritic cell maturation. European Journal of Immunology 2004, 34(2):398-407.
84. Ginhoux F., Liu K., Helft J., et al. The origin and development of nonlymphoid tissue CD103+ DCs. Journal of Experimental Medicine 2009, 206(13):3115-3130.
85. Goubier A., Dubois B., Gheit H., et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008, 29(3):464-475.
86. Guermonprez P., Saveanu L., Kleijmeer M., et al. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature 2003, 425(6956):397-402.
87. Guermonprez P., Valladeau J., Zitvogel L., Théry C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annual Review of Immunology 2002, 20:621-667.
88. Guilliams M., Bruhns P., Saeys Y., Hammad H., Lambrecht B.N. The function of Fcγ receptors in dendritic cells and macrophages. Nature Reviews. Immunology 2014, 14:94-108.
89. Guilliams M., Crozat K., Henri S., et al. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells. Blood 2010, 115(10):1958-1968.
90. Guilliams M., Ginhoux F., Jakubzick C., et al. Dendritic cells, monocytes and macrophages: A unified nomenclature based on ontogeny. Nature Reviews. Immunology 2014, 14(8):571-578.
91. den Haan J.M.M., Bevan M.J. Constitutive versus activation-dependent cross-presentation of immune complexes by CD8+ and CD8- dendritic cells in vivo. Journal of Experimental Medicine 2002, 196(6):817-827.
92. den Haan J.M.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. Journal of Experimental Medicine 2000, 192(12):1685-1696.
93. Hacker C., Kirsch R.D., Ju X.S., et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nature Immunology 2003, 4(4):380-386.
94. Hadeiba H., Sato T., Habtezion A., et al. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nature Immunology 2008, 9(11):1253-1260.
95. Haller Hasskamp J., Zapas J.L., Elias E.G. Dendritic cell counts in the peripheral blood of healthy adults. American Journal of Hematology 2005, 78(4):314-315.
96. Hambleton S., Salem S., Bustamante J., et al. IRF8 mutations and human dendritic-cell immunodeficiency. New England Journal of Medicine 2011, 365(2):127-138.
97. Haniffa M., Shin A., Bigley V., et al. Human tissues contain CD141(hi) cross-presenting dendritic cells with functional homology to mouse CD103(+) nonlymphoid dendritic cells. Immunity 2012, 37(1):60-73.
98. Hänsel A., Günther C., Ingwersen J., et al. Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses. Journal of Allergy and Clinical Immunology 2011, 127(3):787-794.
99. Hashimoto D., Miller J., Merad M. Dendritic cell and macrophage heterogeneity In Vivo. Immunity 2011, 35(3):323-335.
100. Hawiger D., Inaba K., Dorsett Y., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. Journal of Experimental Medicine 2001, 194(6):769-779.
101. Heath W.R., Carbone F.R. Cross-presentation, dendritic cells, tolerance and immunity. Annual Review of Immunology 2001, 19:47-64.
102. Heim R., Cubitt A.B., Tsien R.Y. Improved green fluorescence. Nature 1995, 373(6516):663-664.
103. Helft J., Ginhoux F., Bogunovic M., Merad M. Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunological Reviews 2010, 234(1):55-75.
104. Henri S., Poulin L., Tamoutounour S., et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. Journal of Experimental Medicine 2010, 207:189-206.
105. Hildner K., Edelson B.T., Purtha W.E., et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 2008, 322(5904):1097-1100.
106. Hisamatsu H., Shimbara N. Newly identified pair of proteasomal subunits regulated reciprocally by interferon y. Journal of Experimental Medicine 1996, 183(4):1097-1100.
107. Honey K., Rudensky A.Y. Lysosomal cysteine proteases regulate antigen presentation. Nature Reviews. Immunology 2003, 3:472-482.
108. Hotta C., Fujimaki H., Yoshinari M., Nakazawa M., Minami M. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology 2006, 117(1):97-107.
109. Houde M., Bertholet S., Gagnon E., et al. Phagosomes are competent organelles for antigen cross-presentation. Nature 2003, 425:402-406.
110. Huysamen C., Willment J.A., Dennehy K.M., Brown G.D. CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. Journal of Biological Chemistry 2008, 283(24):16693-16701.
111. Idoyaga J., Cheong C., Suda K., et al. Cutting edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. Journal of immunology (Baltimore, MD: 1950) 2008, 180(6):3647-3650.
112. Idoyaga J., Suda N., Suda K., Park C.G., Steinman R.M. Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(5):1524-1529.
113. Igyártó B.Z., Haley K., Ortner D., et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 2011, 35(2):260-272.
114. Ireland J.M., Unanue E.R. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. Journal of Experimental Medicine 2011, 208(13):2625-2632.
115. Iwasaki A. Mucosal dendritic cells. Annual Review of Immunology 2007, 25:381-418.
116. Iyoda T., Shimoyama S., Liu K., et al. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. Journal of Experimental Medicine 2002, 195(10):1289-1302.
117. Janeway C.A. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annual Review of Immunology 1992, 10:645-674.
118. Jensen P.E. Recent advances in antigen processing and presentation. Nature Immunology 2007, 8(10):1041-1048.
119. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nature Reviews. Immunology 2012, 12(8):557-569.
120. Jongbloed S.L., Benson R.A., Nickdel M.B., et al. Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. Journal of Immunology 2009, 182(2):963-968.
121. Jongbloed S.L., Kassianos A.J., McDonald K.J., et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine 2010, 207(6):1247-1260.
122. Joyce S. Traffic control of completely assembled MHC class I molecules beyond the endoplasmic reticulum. Journal of Molecular Biology 1997, 266(5):993-1001.
123. Kamath A.T., Pooley J., O'Keeffe M.A., et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. Journal of Immunology 2000, 165(12):6762-6770.
124. Kamphorst A.O., Guermonprez P., Dudziak D., Nussenzweig M.C. Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. Journal of Immunology (Baltimore, MD: 1950) 2010, 185(6):3426-3435.
125. Kanaseki T., Blanchard N., Hammer G.E., Gonzalez F., Shastri N. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006, 25(5):795-806.
126. Kang H.-K., Liu M., Datta S.K. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. Journal of Immunology 2007, 178(12):7849-7858.
127. Kang R., Zeh H.J., Lotze M.T., Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death and Differentiation 2011, 18(4):571-580.
128. Kaplan D.H. In vivo function of Langerhans cells and dermal dendritic cells. Trends in Immunology 2010, 31(12):446-451.
129. Kaplan D.H., Jenison M.C., Saeland S., Shlomchik W.D., Shlomchik M.J. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005, 23(6):611-620.
130. Karsunky H., Merad M., Cozzio A., Weissman I.L., Manz M.G. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. Journal of Experimental Medicine 2003, 198(2):305-313.
131. Kastenmüller K., Wille-Reece U., Lindsay R.W., et al. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. Journal of Clinical Investigation 2011, 121(5):1782-1796.
132. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Annals of the New York Academy of Sciences 2008, 1143:1-20.
133. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34(5):637-650.
134. Kim T.S., Braciale T.J. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 2009, 4:e4204.
135. King I.L., Kroenke M.A., Segal B.M. GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. Journal of Experimental Medicine 2010, 207(5):953-961.
136. Kisselev A.F., Akopian T.N., Woo K.M., Goldberg A.L. The sizes of peptides generated from protein by mammalian 26 and 20S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. Journal of Biological Chemistry 1999, 274:3363-3371.
137. Kissenpfennig A., Henri S., Dubois B., et al. Dynamics and function of Langerhans cells in vivo: Dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005, 22(5):643-654.
138. Klechevsky E. Human dendritic cells - Stars in the skin. European Journal of Immunology 2013, 43(12):3147-3155.
139. Klechevsky E., Morita R., Liu M., et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 2008, 29(3):497-510.
140. Kloetzel P.M., Ossendorp F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Current Opinion in Immunology 2004, 16:76-81.
141. Konermann A., Deschner J., Allam J.P., et al. Antigen-presenting cell marker expression and phagocytotic activity in periodontal ligament cells. Journal of Oral Pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2012, 41(4):340-347.
142. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (New York, NY) 1995, 267:243-246.
143. Kraal B.Y.G., Breel M., Janse M., Bruin G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. Journal of Experimental Medicine 1986, 163(April):981-997.
144. Kreer C., Rauen J., Zehner M., Burgdorf S. Cross-presentation: How to get there - Or how to get the ER. Frontiers in Immunology 2012, 2:87.
145. Kroemer G., Mariño G., Levine B. Autophagy and the integrated stress response. Molecular Cell 2010, 40(2):280-293.
146. Kurts C., Robinson B.W.S., Knolle P.A. Cross-priming in health and disease. Nature Reviews. Immunology 2010, 10(6):403-414.
147. Langlet C., Tamoutounour S., Henri S., et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. Journal of Immunology 2012, 188(4):1751-1760.
148. Lanier L.L. NK cell recognition. Annual Review of Immunology 2005, 23:225-274.
149. Lecker S.H., Goldberg A.L., Mitch W.E. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. Journal of the American Society of Nephrology: JASN 2006, 17(11):1807-1819.
150. Lee H.K., Mattei L.M., Steinberg B.E., et al. In Vivo Requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32(2):227-239.
151. Li P., Gregg J.L., Wang N., et al. Compartmentalization of class II antigen presentation: Contribution of cytoplasmic and endosomal processing. Immunological Reviews 2005, 207:206-217.
152. Lindquist R.L., Shakhar G., Dudziak D., et al. Visualizing dendritic cell networks in vivo. Nature Immunology 2004, 5(12):1243-1250.
153. Liu K., Nussenzweig M.C. Origin and development of dendritic cells. Immunological Reviews 2010, 234(1):45-54.
154. Loschko J., Heink S., Hackl D., et al. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity. Journal of Immunology (Baltimore, MD: 1950) 2011, 186(12):6346-6356.
155. Loschko J., Schlitzer A., Dudziak D., et al. Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity. Journal of Immunology (Baltimore, MD: 1950) 2011, 186(12):6718-6725.
156. Loureiro J., Ploegh H.L. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Advances in Immunology 2006, 92(06):225-305.
157. Lucchiari-Hartz M., van Endert P.M., Lauvau G., et al. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes. Journal of Experimental Medicine 2000, 191(2):239-252.
158. van der Lugt B., Khan A.A., Hackney J.A., et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nature Immunology 2014, 15(2):161-167.
159. Lundberg K., Albrekt A.S., Nelissen I., et al. Transcriptional profiling of human dendritic cell populations and models--unique profiles of in vitro dendritic cells and implications on functionality and applicability. PLoS One 2013, 8(1):e52875.
160. Luzio J.P., Gray S.R., Bright N.A. Endosome-lysosome fusion. Biochemical Society Transactions 2010, 38:1413-1416.
161. MacDonald K.P.A., Munster D.J., Clark G.J., et al. Characterization of human blood dendritic cell subsets. Blood 2002, 100(13):4512-4520.
162. Maldonado-López R., De Smedt T., Michel P., et al. CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. Journal of Experimental Medicine 1999, 189(3):587-592.
163. Malissen B., Tamoutounour S., Henri S. The origins and functions of dendritic cells and macrophages in the skin. Nature Reviews. Immunology 2014, 14(6):417-428.
164. Manoury B., Hewitt E.W., Morrice N., et al. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation. Nature 1998, 396(1997):695-699.
165. Maric M., Arunachalam B., Phan U.T., et al. Defective antigen processing in GILT-free mice. Science (New York, NY) 2001, 294(5545):1361-1365.
166. Martín-Fontecha A., Sebastiani S., Höpken U.E., et al. Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. Journal of Experimental Medicine 2003, 198(4):615-621.
167. McGovern N., Chan J.K.Y., Ginhoux F. Dendritic cells in humans - From fetus to adult. International Immunology 2014, 27(2):65-72.
168. McGovern N., Schlitzer A., Gunawan M., et al. Human dermal CD14+ cells are a transient population of monocyte-derived macrophages. Immunity 2014, 41(3):465-477.
169. McLellan A.D., Kapp M., Eggert A., et al. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood 2002, 99(6):2084-2093.
170. Mcllroy D., Troadec C., Grassi F., et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood 2001, 97(11):3470-3477.
171. Meissner F., Mann M. Quantitative shotgun proteomics: Considerations for a high-quality workflow in immunology. Nature Immunology 2014, 15(2):112-117.
172. Mellman I., Steinman R.M. Dendritic cells: Specialized and regulated antigen processing machines. Cell 2001, 106(3):255-258.
173. Merad M., Ginhoux F., Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Reviews. Immunology 2008, 8(12):935-947.
174. Merad M., Manz M. Dendritic cell homeostasis. Blood 2009, 113(15):3418-3427.
175. Merad M., Sathe P., Helft J., Miller J., Mortha A. The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annual Review of Immunology 2013, 31:563-604.
176. Meredith M.M., Liu K., Kamphorst A.O., et al. Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. Journal of Experimental Medicine 2012, 209(9):1583-1593.
177. Metzger M.B., Pruneda J.N., Klevit R.E., Weissman A.M. RING-type E3 ligases: Master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. Biochimica et Biophysica Acta - Molecular Cell Research 2014, 1843(1):47-60.
178. Miller J.C., Brown B.D., Shay T., et al. Deciphering the transcriptional network of the dendritic cell lineage. Nature Immunology 2012, 13(9):888-899.
179. Mintern J.D., Macri C., Villadangos J.A. Modulation of antigen presentation by intracellular trafficking. Current Opinion in Immunology 2015, 34:16-21.
180. Mittag D., Proietto A.I., Loudovaris T., et al. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. Journal of Immunology (Baltimore, MD: 1950) 2011, 186(11):6207-6217.
181. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451(7182):1069-1075.
182. Mizushima N., Noda T., Yoshimori T., et al. A protein conjugation system essential for autophagy. Nature 1998, 395(6700):395-398.
183. Moffat J.M., Mintern J.D., Villadangos J.A. Control of MHC II antigen presentation by ubiquitination. Current Opinion in Immunology 2013, 25(1):109-114.
184. Moffat J.M., Segura E., Khoury G., et al. Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation. European Journal of Immunology 2013, 43(3):595-605.
185. Mohamed M.M., Sloane B.F. Cysteine cathepsins: Multifunctional enzymes in cancer. Nature Reviews. Cancer 2006, 6:764-775.
186. Mollah S.A., Dobrin J.S., Feder R.E., et al. Flt3L dependence helps define an uncharacterized subset of murine cutaneous dendritic cells. Journal of Investigative Dermatology 2014, 134(5):1265-1275.
187. van Montfoort N., Camps M.G., Khan S., et al. Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(16):6730-6735.
188. Morris S., Swanson M.S., Lieberman A., et al. Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. Journal of immunology (Baltimore, MD: 1950) 2011, 187:3953-3961.
189. Münz C. Enhancing immunity through autophagy. Annual Review of Immunology 2009, 27:423-449.
190. Nagao K., Ginhoux F., Leitner W.W., et al. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(9):3312-3317.
191. Nakagawa T.Y., Brissette W.H., Lira P.D., et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999, 10:207-217.
192. Nestle F.O., Turka L.A., Nickoloff B.J. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. Journal of Clinical Investigation 1994, 94(1):202-209.
193. Neubert K., Lehmann C.H., Heger L., et al. Antigen delivery to CD11c+CD8- dendritic cells induces protective immune responses against experimental melanoma in mice In Vivo. Journal of Immunology 2014, 192(12):5830-5838.
194. Newcomb J.R., Carboy-Newcomb C., Cresswell P. Trimeric interactions of the invariant chain and its association with major histocompatibility complex class II alpha beta dimers. Journal of Biological Chemistry 1996, 271(39):24249-24256.
195. Newell E.W., Sigal N., Nair N., et al. Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization. Nature Biotechnology 2013, 31(7):623-629.
196. Nierkens S., Tel J., Janssen E., Adema G.J. Antigen cross-presentation by dendritic cell subsets: One general or all sergeants?. Trends in Immunology 2013, 1-10.
197. Nimmerjahn F., Milosevic S., Behrends U., et al. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. European Journal of Immunology 2003, 33(5):1250-1259.
198. Nimmerjahn F., Ravetch J.V. Fcgamma receptors: Old friends and new family members. Immunity 2006, 24(1):19-28.
199. Nimmerjahn F., Ravetch J.V. Fcgamma receptors as regulators of immune responses. Nature Reviews. Immunology 2008, 8(1):34-47.
200. Nizzoli G., Krietsch J., Weick A., et al. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 2013, 122(6):932-942.
201. Ochando J.C., Homma C., Yang Y., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nature Immunology 2006, 7(6):652-662.
202. O'Donnell E.A., Ernst D.N., Hingorani R. Multiparameter flow cytometry: Advances in high resolution analysis. Immune Network 2013, 13(2):43-54.
203. Paessens L., Fluitsma D., van Kooyk Y. Haematopoietic antigen-presenting cells in the human thymic cortex: Evidence for a role in selection and removal of apoptotic thymocytes. Journal of Pathology 2008, 214(1):96-103.
204. Pandey G., Cohain A., Miller J., Merad M. Decoding dendritic cell function through module and network analysis. Journal of Immunological Methods 2013, 387(1-2):71-80.
205. Perfetto S.P., Chattopadhyay P.K., Roederer M. Seventeen-colour flow cytometry: Unravelling the immune system. Nature Reviews. Immunology 2004, 4(8):648-655.
206. Phan U.T., Arunachalam B., Cresswell P. Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. Journal of Biological Chemistry 2000, 275(34):25907-25914.
207. Piatkevich K.D., Verkhusha V.V. Guide to red fluorescent proteins and biosensors for flow cytometry. Methods in Cell Biology 2011, 102:431-461.
208. Pierre P., Mellman I. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998, 93:1135-1145.
209. Poluektov Y.O., Kim A., Hartman I.Z., Sadegh-Nasseri S. HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. PLoS One 2013, 8:e71228.
210. Pooley J.L., Heath W.R., Shortman K. Cutting edge: Intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. Journal of Immunology (Baltimore, MD: 1950) 2001, 166(9):5327-5330.
211. Poulin L.F., Henri S., de Bovis B., et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. Journal of Experimental Medicine 2007, 204(13):3119-3131.
212. Poulin L.F., Salio M., Griessinger E., et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8α+ dendritic cells. Journal of Experimental Medicine 2010, 207(6):1261-1271.
213. Pulendran B., Smith J.L., Caspary G., et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(3):1036-1041.
214. Pulendran B., Tang H., Denning T.L. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Current Opinion in Immunology 2008, 20(1):61-67.
215. Qiu C.-H., Miyake Y., Kaise H., et al. Novel subset of CD8α+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. Journal of Immunology (Baltimore, MD: 1950) 2009, 182(7):4127-4136.
216. Ravikumar B., Sarkar S., Davies J.E., et al. Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews 2010, 90:1383-1435.
217. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: Recent progress and open questions. Annual Review of Immunology 2011, 29:163-183.
218. Riese R.J., Chapman H.A. Cathepsins and compartmentalization in antigen presentation. Current Opinion in Immunology 2000, 12(1):107-113.
219. Riese R.J., Wolf P.R., Brömme D., et al. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996, 4(4):357-366.
220. Robbins S.H., Walzer T., Dembélé D., et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biology 2008, 9(1):R17.
221. Roche P.A., Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nature Reviews Immunology 2015, 15:203-216.
222. Rock K.L., Farfán-Arribas D.J., Colbert J.D., Goldberg A.L. Re-examining class-I presentation and the DRiP hypothesis. Trends in Immunology 2014, 35(4):144-152.
223. Rock K.L., Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annual Review of Immunology 1999, 17:739-779.
224. Rock K.L., Shen L. Cross-presentation: Underlying mechanisms and role in immune surveillance. Immunological Reviews 2005, 207:166-183.
225. Rock K.L., York I.A., Goldberg A.L. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nature Immunology 2004, 5(7):670-677.
226. Rodriguez A., Regnault A., Kleijmeer M., et al. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nature Cell Biology 1999, 1(6):362-368.
227. Romani N., Clausen B.E., Stoitzner P. Langerhans cells and more: Langerin-expressing dendritic cell subsets in the skin. Immunological Reviews 2010, 234(1):120-141.
228. Romani N., Thurnher M., Idoyaga J., Steinman R.M., Flacher V. Targeting of antigens to skin dendritic cells: Possibilities to enhance vaccine efficacy. Immunology and Cell Biology 2010, 234:1-7.
229. Rönnblom L. Potential role of IFN in adult lupus. Arthritis Research & Therapy 2010, 12(Suppl. 1):S3.
230. Sahu R., Kaushik S., Clement C.C., et al. Microautophagy of cytosolic proteins by late endosomes. Developmental Cell 2011, 20(1):131-139.
231. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus Iuterleukin 4 and downregulated by tumor necrosis factor ?. Journal of Experimental Medicine 1994, 179(1):1109-1118.
232. Sancho D., Joffre O.P., Keller A.M., et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 2009, 458(7240):899-903.
233. Sapoznikov A., Fischer J.A., Zaft T., et al. Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. Journal of Experimental Medicine 2007, 204(8):1923-1933.
234. Saric T., Beninga J., Graef C.I., et al. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. Journal of Biological Chemistry 2001, 276(39):36474-36481.
235. Satpathy A.T., Murphy K.M., Wumesh K.C. Transcription factor networks in dendritic cell development. Seminars in Immunology 2011, 23(5):388-397.
236. Satpathy A.T., Wu X., Albring J.C., et al. Re(de)fining the dendritic cell lineage. Nature Immunology 2012, 13(12):1145-1154.
237. Saveanu L., Carroll O., Weimershaus M., et al. IRAP identifies an endosomal compartment required for MHC class I cross-presentation. Science (New York, NY) 2009, 325(5937):213-217.
238. Savina A., Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunological Reviews 2007, 219:143-156.
239. Savina A., Peres A., Cebrian I., et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8+ dendritic cells. Immunity 2009, 30(4):544-555.
240. Sawai C.M., Sisirak V., Ghosh H.S., et al. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. Journal of Experimental Medicine 2013, 210(11):2151-2159.
241. Schäkel K., Kannagi R., Kniep B., et al. 6-Sulfo LacNAc, a novel carbohydrate modification of PSGL-1, defines an inflammatory type of human dendritic cells. Immunity 2002, 17(3):289-301.
242. Schatz M.M., Peters B., Akkad N., et al. Characterizing the N-terminal processing motif of MHC class I ligands. Journal of Immunology (Baltimore, MD: 1950) 2008, 180:3210-3217.
243. Schlitzer A., Ginhoux F. Organization of the mouse and human DC network. Current Opinion in Immunology 2014, 26(1):90-99.
244. Schlitzer A., McGovern N., Teo P., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013, 38(5):970-983.
245. Schmid D., Pypaert M., Münz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26(1):79-92.
246. Schnorrer P., Behrens G.M., Wilson N.S., et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(28):10729-10734.
247. Schraml B.U., Reis e Sousa C. Defining dendritic cells. Current Opinion in Immunology 2015, 32:13-20.
248. Schubert U., Antón L.C., Gibbs J., et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 2000, 404:770-774.
249. Schuler G., Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. Journal of Experimental Medicine 1985, 161:526-546.
250. Schulz O., Edwards A.D., Schito M., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000, 13(4):453-462.
251. Schulz O., Jaensson E., Persson E.K., et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. Journal of Experimental Medicine 2009, 206(13):3101-3114.
252. Schulz O., Reis E Sousa C. Cross-presentation of cell-associated antigens by CD8??+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 2002, 107(2):183-189.
253. Schumacher T.N., De Bruijn M.L., Vernie L.N., et al. Peptide selection by MHC class I molecules. Nature 1991, 350:703-706.
254. Schwartz R.H. T cell anergy. Annual Review of Immunology 2003, 21(1):305-334.
255. Segura E., Amigorena S. Cross-presentation by human dendritic cell subsets. Immunology Letters 2014, 158(1-2):73-78.
256. Segura E., Durand M., Amigorena S. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells. Journal of Experimental Medicine 2013, 210(5):1035-1047.
257. Segura E., Valladeau-Guilemond J., Donnadieu M.H., et al. Characterization of resident and migratory dendritic cells in human lymph nodes. Journal of Experimental Medicine 2012, 209(4):653-660.
258. Segura E., Villadangos J.A. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic (Copenhagen, Denmark) 2011, 12(12):1677-1685.
259. Severa M., Giacomini E., Gafa V., et al. EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: Implications for viral immune escape. European Journal of Immunology 2013, 43:147-158.
260. Shen L., Rock K.L. Cellular protein is the source of cross-priming antigen in vivo. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(9):3035-3040.
261. Shortman K., Liu Y.-J. Mouse and human dendritic cell subtypes. Nature Reviews Immunology 2002, 2(3):151-161.
262. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nature Reviews. Immunology 2007, 7(1):19-30.
263. Silk J.D., Salio M., Brown J., Jones E.Y., Cerundolo V. Structural and functional aspects of lipid binding by CD1 molecules. Annual Review of Cell and Developmental Biology 2008, 24:369-395.
264. Singh R., Cresswell P. Defective cross-presentation of viral antigens in GILT-free mice. Science (New York, NY) 2010, 328(5984):1394-1398.
265. Skokos D., Nussenzweig M.C. CD8- DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. Journal of Experimental Medicine 2007, 204(7):1525-1531.
266. Smith M.H., Ploegh H.L., Weissman J.S. Road to ruin: Targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334(6059):1086-1090.
267. Soares H., Waechter H., Glaichenhaus N., et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. Journal of Experimental Medicine 2007, 204(5):1095-1106.
268. Song R., Harding C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. Journal of Immunology (Baltimore, MD: 1950) 1996, 156(34):4182-4190.
269. Steinman R.M. Decisions about dendritic cells: Past, present, and future. Annual Review of Immunology 2012, 30:1-22.
270. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice I. Morphology, quantitation, tissue distribution. Journal of Experimental Medicine 1973, 137:1142-1162.
271. Steinman R.M., Hawiger D., Nussenzweig M.C. Tolerogenic dendritic cells. Annual Review of Immunology 2003, 21:685-711.
272. Steinman R.M., Nussenzweig M.C. Dendritic cells: Features and functions. Immunological Reviews 1980, 53:127-147.
273. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(1):351-358.
274. Stoitzner P., Holzmann S., McLellan A.D., et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. Journal of Investigative Dermatology 2003, 120(2):266-274.
275. Suzuki S., Honma K., Matsuyama T., et al. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(24):8981-8986.
276. Swiecki M., Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunological Reviews 2010, 234(1):142-162.
277. Tamoutounour S., Guilliams M., Montanana Sanchis F., et al. Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 2013, 39(5):925-938.
278. Thaiss C.A., Semmling V., Franken L., Wagner H., Kurts C. Chemokines: A new dendritic cell signal fort cell activation. Frontiers in Immunology 2011, 2:1-9.
279. Tosello V., Zamarchi R., Merlo A., et al. Differential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4. European Journal of Immunology 2009, 39(1):56-66.
280. Trombetta S., Mellman I. Cell biology of antigen processing in vitro and in vivo. Annual Review of Immunology 2005, 23:975-1028.
281. Tsien R.Y. The green fluorescent protein. Annual Review of Biochemistry 1998, 67:509-544.
282. Tu L., Fang T.C., Artis D., et al. Notch signaling is an important regulator of type 2 immunity. Journal of Experimental Medicine 2005, 202(8):1037-1042.
283. Vega-Ramos J., Roquilly A., Asehnoune K., Villadangos J.A. Modulation of dendritic cell antigen presentation by pathogens, tissue damage and secondary inflammatory signals. Current Opinion in Pharmacology 2014, 17:64-70.
284. Villadangos J.A. Presentation of antigens by MHC class II molecules: Getting the most out of them. Molecular Immunology 2001, 38:329-346.
285. Villadangos J.A., Heath W.R., Carbone F.R. Outside looking in: The inner workings of the crosspresentation pathway within dendritic cells. Trends in Immunology 2007, 28(2):45-47.
286. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nature Reviews Immunology 2007, 7(7):543-555.
287. Villadangos J.A., Young L.J. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008, 29(3):352-361.
288. Voges D., Zwickl P., Baumeister W. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annual Review of Biochemistry 1999, 68:1015-1068.
289. Vremec D., Pooley J., Hochrein H., Wu L., Shortman K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. Journal of Immunology (Baltimore, MD: 1950) 2000, 164(6):2978-2986.
290. Vremec D., Zorbas M., Scollay R., et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: Investigation of the CD8 expression by a subpopulation of dendritic cells. Journal of Experimental Medicine 1992, 176(1):47-58.
291. Waskow C., Liu K., Darrasse-Jèze G., et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nature Immunology 2008, 9(6):676-683.
292. Watchmaker P.B., Lahl K., Lee M., et al. Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. Nature Immunology 2014, 15(1):98-108.
293. Watts C., Matthews S.P., Mazzeo D., Manoury B., Moss C.X. Asparaginyl endopeptidase: Case history of a class II MHC compartment protease. Immunological Reviews 2005, 207:218-228.
294. Wearsch P.A., Cresswell P. The quality control of MHC class I peptide loading. Current Opinion in Cell Biology 2008, 20:624-631.
295. Weimershaus M., Evnouchidou I., Saveanu L., van Endert P. Peptidases trimming MHC class I ligands. Current Opinion in Immunology 2013, 25(1):90-96.
296. Weimershaus M., Maschalidi S., Sepulveda F., et al. Conventional dendritic cells require IRAP-Rab14 endosomes for efficient cross-presentation. Journal of Immunology (Baltimore, MD: 1950) 2012, 188:1840-1846.
297. Wendland M., Czeloth N., Mach N., et al. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(15):6347-6352.
298. Xue J., Schmidt S.V., Sander J., et al. Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation. Immunity 2014, 40(2):274-288.
299. Yamazaki S., Dudziak D., Heidkamp G.F., et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. Journal of Immunology 2008, 181(10):6923-6933.
300. Yasuda Y., Kaleta J., Brömme D. The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics. Advanced Drug Delivery Reviews 2005, 57:973-993.
301. Yewdell J.W., Antón L.C., Bennink J.R. Defective ribosomal products (DRiPs): A major source of antigenic peptides for MHC class I molecules?. Journal of Immunology (Baltimore, MD: 1950) 1996, 157:1823-1826.
302. Yoneyama M., Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunological Reviews 2009, 227(1):54-65.
303. York I.A., et al. The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 2003, 18:429-440.
304. Young L.J., Wilson N.S., Schnorrer P., et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nature Immunology 2008, 9(11):1244-1252.
305. Yu C.I., Becker C., Metang P., et al. Human CD141+ Dendritic Cells Induce CD4+ T Cells To Produce Type 2 Cytokines. Journal of Immunology 2014, 193(12):6210.
306. Zhang J., Raper A., Sugita N., et al. Characterization of siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 2006, 107(9):3600-3608.
307. Zhang Y., Baig E., Williams D.B. Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules. Journal of Biological Chemistry 2006, 281(21):14622-14631.
308. Ziegler-Heitbrock L., Ancuta P., Crowe S., et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116(16):e74-e80.